Innovative Blood Test Detects Brain Cancer in Under an Hour

University of Notre Dame researchers develop a low-cost, rapid diagnostic tool for glioblastoma using electrokinetic technology.

The device uses a biochip to detect active EGFRs in extracellular vesicles from blood samples.
Tests can be completed in less than 60 minutes with high sensitivity and selectivity.
Each biochip costs under $2, making the test affordable and accessible.
The technology can potentially be adapted for other diseases such as pancreatic cancer and cardiovascular disorders.
Early detection through this method could improve survival rates for glioblastoma patients.